Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Tercel, M; Lee, AE; Hogg, A; Anderson, RF; Lee, HH; Siim, BG; Denny, WA; Wilson, WR
   Hypoxia-selective antitumor agents. 16. Nitroarylmethyl quaternary salts as bioreductive prodrugs of the alkylating agent mechlorethamine
   JOURNAL OF MEDICINAL CHEMISTRY
   
   M. Tercel et al., "Hypoxia-selective antitumor agents. 16. Nitroarylmethyl quaternary salts as bioreductive prodrugs of the alkylating agent mechlorethamine", J MED CHEM, 44(21), 2001, pp. 3511-3522
2. Kestell, P; Pruijn, FB; Siim, BG; Palmer, BD; Wilson, WR
   Pharmacokinetics and metabolism of the nitrogen mustard bioreductive drug 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide (SN 23862) and the corresponding aziridine (CB 1954) in KHT tumour-bearing mice
   CANCER CHEMOTHERAPY AND PHARMACOLOGY
   
   P. Kestell et al., "Pharmacokinetics and metabolism of the nitrogen mustard bioreductive drug 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide (SN 23862) and the corresponding aziridine (CB 1954) in KHT tumour-bearing mice", CANC CHEMOT, 46(5), 2000, pp. 365-374
3. Siim, BG; Laux, WT; Rutland, MD; Palmer, BN; Wilson, WR
   Scintigraphic imaging of the hypoxia marker (99m)technetium-labeled 2,2 '-(1,4-diaminobutane)bis(2-methyl-3-butanone) dioxime (Tc-99m-labeled HL-91; Prognox): Noninvasive detection of tumor response to the antivascular agent5,6-dimethylxanthenone-4-acetic acid
   CANCER RESEARCH
   
   B.G. Siim et al., "Scintigraphic imaging of the hypoxia marker (99m)technetium-labeled 2,2 '-(1,4-diaminobutane)bis(2-methyl-3-butanone) dioxime (Tc-99m-labeled HL-91; Prognox): Noninvasive detection of tumor response to the antivascular agent5,6-dimethylxanthenone-4-acetic acid", CANCER RES, 60(16), 2000, pp. 4582-4588
4. Siim, BG; Hicks, KO; Pullen, SM; van Zijl, PL; Denny, WA; Wilson, WR
   Comparison of aromatic and tertiary amine N-oxides of acridine DNA intercalators as bioreductive drugs - Cytotoxicity, DNA binding, cellular uptake, and metabolism
   BIOCHEMICAL PHARMACOLOGY
   
   B.G. Siim et al., "Comparison of aromatic and tertiary amine N-oxides of acridine DNA intercalators as bioreductive drugs - Cytotoxicity, DNA binding, cellular uptake, and metabolism", BIOCH PHARM, 60(7), 2000, pp. 969-978
5. WILSON WR; LI AE; COWAN DSM; SIIM BG
   ENHANCEMENT OF TUMOR RADIATION RESPONSE BY THE ANTIVASCULAR AGENT 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID
   International journal of radiation oncology, biology, physics
   
   W.R. Wilson et al., "ENHANCEMENT OF TUMOR RADIATION RESPONSE BY THE ANTIVASCULAR AGENT 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID", International journal of radiation oncology, biology, physics, 42(4), 1998, pp. 905-908
6. HICKS KO; FLEMING Y; SIIM BG; KOCH CJ; WILSON WR
   EXTRAVASCULAR DIFFUSION OF TIRAPAZAMINE - EFFECT OF METABOLIC CONSUMPTION ASSESSED USING THE MULTICELLULAR LAYER MODEL
   International journal of radiation oncology, biology, physics
   
   K.O. Hicks et al., "EXTRAVASCULAR DIFFUSION OF TIRAPAZAMINE - EFFECT OF METABOLIC CONSUMPTION ASSESSED USING THE MULTICELLULAR LAYER MODEL", International journal of radiation oncology, biology, physics, 42(3), 1998, pp. 641-649
7. SIIM BG; DENNY WA; WILSON WR
   NITRO REDUCTION AS AN ELECTRONIC SWITCH FOR BIOREDUCTIVE DRUG ACTIVATION
   Oncology research
   
   B.G. Siim et al., "NITRO REDUCTION AS AN ELECTRONIC SWITCH FOR BIOREDUCTIVE DRUG ACTIVATION", Oncology research, 9(6-7), 1997, pp. 357-369
8. SIIM BG; ATWELL GJ; ANDERSON RF; WARDMAN P; PULLEN SM; WILSON WR; DENNY WA
   HYPOXIA-SELECTIVE ANTITUMOR AGENTS .15. MODIFICATION OF RATE OF NITROREDUCTION AND EXTENT OF LYSOSOMAL UPTAKE BY POLYSUBSTITUTION OF 4-(ALKYLAMINO)-5-NITROQUINOLINE BIOREDUCTIVE DRUGS
   Journal of medicinal chemistry
   
   B.G. Siim et al., "HYPOXIA-SELECTIVE ANTITUMOR AGENTS .15. MODIFICATION OF RATE OF NITROREDUCTION AND EXTENT OF LYSOSOMAL UPTAKE BY POLYSUBSTITUTION OF 4-(ALKYLAMINO)-5-NITROQUINOLINE BIOREDUCTIVE DRUGS", Journal of medicinal chemistry, 40(9), 1997, pp. 1381-1390
9. SIIM BG; MENKE DR; DORIE MJ; BROWN JM
   TIRAPAZAMINE-INDUCED CYTOTOXICITY AND DNA-DAMAGE IN TRANSPLANTED TUMORS - RELATIONSHIP TO TUMOR HYPOXIA
   Cancer research
   
   B.G. Siim et al., "TIRAPAZAMINE-INDUCED CYTOTOXICITY AND DNA-DAMAGE IN TRANSPLANTED TUMORS - RELATIONSHIP TO TUMOR HYPOXIA", Cancer research, 57(14), 1997, pp. 2922-2928
10. ELWELL JH; SIIM BG; EVANS JW; BROWN JM
    ADAPTATION OF HUMAN TUMOR-CELLS TO TIRAPAZAMINE UNDER AEROBIC CONDITIONS - IMPLICATIONS OF INCREASED ANTIOXIDANT ENZYME-ACTIVITY TO MECHANISM OF AEROBIC CYTOTOXICITY
    Biochemical pharmacology
    
    J.H. Elwell et al., "ADAPTATION OF HUMAN TUMOR-CELLS TO TIRAPAZAMINE UNDER AEROBIC CONDITIONS - IMPLICATIONS OF INCREASED ANTIOXIDANT ENZYME-ACTIVITY TO MECHANISM OF AEROBIC CYTOTOXICITY", Biochemical pharmacology, 54(2), 1997, pp. 249-257
11. SIIM BG; VANZIJL PL; BROWN JM
    TIRAPAZAMINE-INDUCED DNA-DAMAGE MEASURED USING THE COMET ASSAY CORRELATES WITH CYTOTOXICITY TOWARDS HYPOXIC TUMOR-CELLS IN-VITRO
    British Journal of Cancer
    
    B.G. Siim et al., "TIRAPAZAMINE-INDUCED DNA-DAMAGE MEASURED USING THE COMET ASSAY CORRELATES WITH CYTOTOXICITY TOWARDS HYPOXIC TUMOR-CELLS IN-VITRO", British Journal of Cancer, 73(8), 1996, pp. 952-960
12. SIIM BG; WILSON WR
    EFFICIENT REDOX CYCLING OF NITROQUINOLINE BIOREDUCTIVE DRUGS DUE TO AEROBIC NITROREDUCTION IN CHINESE-HAMSTER CELLS
    Biochemical pharmacology
    
    B.G. Siim e W.R. Wilson, "EFFICIENT REDOX CYCLING OF NITROQUINOLINE BIOREDUCTIVE DRUGS DUE TO AEROBIC NITROREDUCTION IN CHINESE-HAMSTER CELLS", Biochemical pharmacology, 50(1), 1995, pp. 75-82
13. SIIM BG; DENNY WA; WILSON WR
    DOES DNA TARGETING AFFECT THE CYTOTOXICITY AND CELL UPTAKE OF BASIC NITROQUINOLINE BIOREDUCTIVE DRUGS
    International journal of radiation oncology, biology, physics
    
    B.G. Siim et al., "DOES DNA TARGETING AFFECT THE CYTOTOXICITY AND CELL UPTAKE OF BASIC NITROQUINOLINE BIOREDUCTIVE DRUGS", International journal of radiation oncology, biology, physics, 29(2), 1994, pp. 311-315
14. SIIM BG; ATWELL GJ; WILSON WR
    OXYGEN DEPENDENCE OF THE CYTOTOXICITY AND METABOLIC-ACTIVATION OF 4-ALKYLAMINO-5-NITROQUINOLINE BIOREDUCTIVE DRUGS
    British Journal of Cancer
    
    B.G. Siim et al., "OXYGEN DEPENDENCE OF THE CYTOTOXICITY AND METABOLIC-ACTIVATION OF 4-ALKYLAMINO-5-NITROQUINOLINE BIOREDUCTIVE DRUGS", British Journal of Cancer, 70(4), 1994, pp. 596-603
15. SIIM BG; ATWELL GJ; WILSON WR
    METABOLIC AND RADIOLYTIC REDUCTION OF 4-ALKYLAMINO-5-NITROQUINOLINE BIOREDUCTIVE DRUGS - RELATIONSHIP TO HYPOXIA-SELECTIVE CYTOTOXICITY
    Biochemical pharmacology
    
    B.G. Siim et al., "METABOLIC AND RADIOLYTIC REDUCTION OF 4-ALKYLAMINO-5-NITROQUINOLINE BIOREDUCTIVE DRUGS - RELATIONSHIP TO HYPOXIA-SELECTIVE CYTOTOXICITY", Biochemical pharmacology, 48(8), 1994, pp. 1593-1604
16. SIIM BG; ATWELL GJ; WILSON WR
    METABOLIC AND RADIOLYTIC REDUCTION OF 4-ALKYLAMINO-5-NITROQUINOLINE BIOREDUCTIVE DRUGS - RELATIONSHIP TO HYPOXIA-SELECTIVE CYTOTOXICITY
    Biochemical pharmacology
    
    B.G. Siim et al., "METABOLIC AND RADIOLYTIC REDUCTION OF 4-ALKYLAMINO-5-NITROQUINOLINE BIOREDUCTIVE DRUGS - RELATIONSHIP TO HYPOXIA-SELECTIVE CYTOTOXICITY", Biochemical pharmacology, 48(8), 1994, pp. 1593-1604